Works in Cancer Chemotherapy & Pharmacology, 2015, Vol 75, Issue 5
Results: 27
A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Positron emission tomography imaging of human colon cancer xenografts in mice with [18F]fluorothymidine after TAS-102 treatment.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Motesanib with or without panitumumab plus FOLFIRI or FOLFOX for the treatment of metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 993, doi. 10.1007/s00280-015-2694-y
- By:
- Publication type:
- Article
First-in-human, phase I/IIa dose-escalation and safety study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 929, doi. 10.1007/s00280-015-2703-1
- By:
- Publication type:
- Article
Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 1047, doi. 10.1007/s00280-015-2705-z
- By:
- Publication type:
- Article
The effect of food on the pharmacokinetics of oral ibrutinib in healthy participants and patients with chronic lymphocytic leukemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 907, doi. 10.1007/s00280-015-2708-9
- By:
- Publication type:
- Article
Activated STAT3 correlates with prognosis of non-small cell lung cancer and indicates new anticancer strategies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 917, doi. 10.1007/s00280-015-2710-2
- By:
- Publication type:
- Article
Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 923, doi. 10.1007/s00280-015-2711-1
- By:
- Publication type:
- Article
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody targeting the DR5 receptor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 887, doi. 10.1007/s00280-015-2712-0
- By:
- Publication type:
- Article
Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 897, doi. 10.1007/s00280-015-2713-z
- By:
- Publication type:
- Article
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 941, doi. 10.1007/s00280-015-2715-x
- By:
- Publication type:
- Article
Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt-Nrf2-HO-1 signaling and reduction of NADPH oxidase.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 949, doi. 10.1007/s00280-015-2716-9
- By:
- Publication type:
- Article
Mercaptopurine metabolite levels are predictors of bone marrow toxicity following high-dose methotrexate therapy of childhood acute lymphoblastic leukaemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 1089, doi. 10.1007/s00280-015-2717-8
- By:
- Publication type:
- Article
Positron emission tomography imaging of human colon cancer xenografts in mice with [F]fluorothymidine after TAS-102 treatment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 1005, doi. 10.1007/s00280-015-2718-7
- By:
- Publication type:
- Article
Effects of cyclosporine A on the hepatobiliary disposition and hepatic uptake of etoposide in an isolated perfused rat liver model.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 961, doi. 10.1007/s00280-015-2719-6
- By:
- Publication type:
- Article
Dose selection of siltuximab for multicentric Castleman's disease.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 1037, doi. 10.1007/s00280-015-2720-0
- By:
- Publication type:
- Article
Levels of sirolimus in saliva and blood following oral topical sustained-release varnish delivery system application.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 969, doi. 10.1007/s00280-015-2721-z
- By:
- Publication type:
- Article
Plasma pharmacokinetics of the indenoisoquinoline topoisomerase I inhibitor, NSC 743400, in rats and dogs.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 1015, doi. 10.1007/s00280-015-2722-y
- By:
- Publication type:
- Article
Organic cation transporter OCT6 mediates cisplatin uptake and resistance to cisplatin in lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 985, doi. 10.1007/s00280-015-2723-x
- By:
- Publication type:
- Article
Pharmacokinetically based dosing of weekly paclitaxel to reduce drug-related neurotoxicity based on a single sample strategy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 975, doi. 10.1007/s00280-015-2724-9
- By:
- Publication type:
- Article
Vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) rechallenge for patients with metastatic renal cell carcinoma after treatment failure using both VEGFR-TKI and mTOR inhibitor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 1025, doi. 10.1007/s00280-015-2725-8
- By:
- Publication type:
- Article
A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 1065, doi. 10.1007/s00280-015-2728-5
- By:
- Publication type:
- Article
Validation of a fast and low-cost alkaline lysis method for gDNA extraction in a pharmacogenetic context.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 1095, doi. 10.1007/s00280-015-2729-4
- By:
- Publication type:
- Article
Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in Mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 1057, doi. 10.1007/s00280-015-2734-7
- By:
- Publication type:
- Article
A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax) in patients with peritoneal malignancies.
- Published in:
- 2015
- By:
- Publication type:
- Report
Autophagy in cancer stem/progenitor cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 879, doi. 10.1007/s00280-014-2634-2
- By:
- Publication type:
- Article